Markets.com Logo

CLRB

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    4.4258$
  • Previous Close
    4.4802$
  • 52 Week Change
    64.59$
  • Day Range
    -0.05$
  • 52 Week High/Low
    4.11$ - 68.7$
  • Dividend Per Share
    --
  • Market cap
    14 332 K$
  • EPS
    -3.39
  • Beta
    0.419
  • Volume
    --

About

CLRB.US refers to the common stock of Cellectar Biosciences Inc., a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of cancer therapeutics. The ".US" extension typically indicates that the stock is traded on a United States stock exchange, such as NASDAQ or NYSE.

Iran War Threatens US Labor Market's 'Wonderful Balance': A Deep Dive

Emma Rose|--

Iran's Hormuz Toll Strategy: Post-War Economic Leverage and Geopolitical Realignment

Sophia Claire|--

US Labor Market Outlook: Balancing Recovery Against Escalating Geopolitical Risks

Sophia Claire|--

Global Debt Crisis Deepens Amidst Iran Conflict and Fiscal Fragility

Ava Grace|--

Apple's Strategic Pivot: MacBook Neo, Supply Chain Tactics, and Foldable Phone Hurdles

Emma Rose|--

Gold and Silver: The Greatest Bull Market Has Begun - Early Stages and Correction Analysis

Emma Rose|--

US Labor Market Navigates Dual Pressures: External Shocks and Internal Slowdown

Ava Grace|--

Factors

Clinical Trial Results: Positive data from Cellectar Biosciences' clinical trials for its cancer therapies can significantly increase investor confidence and drive the stock price higher, while negative or inconclusive results can have the opposite effect.

Regulatory Approvals: Approval from regulatory bodies like the FDA for Cellectar's drug candidates is a major catalyst for price increases, as it signifies market access and potential revenue generation. Delays or rejections can negatively impact the stock.

Financial Performance: Cellectar's cash reserves, burn rate, and ability to secure funding influence investor sentiment. A strong financial position provides stability and enables continued research and development, while concerns about funding can depress the stock price.

Market Conditions: Overall market trends, particularly in the biotechnology sector, affect CLRB.US. Bull markets generally boost stock prices, while bear markets can exert downward pressure.

Competition: The competitive landscape in the cancer therapy market impacts CLRB.US. Success of competing drugs or therapies can reduce investor interest in Cellectar, while setbacks for competitors may benefit the company.

Partnerships and Collaborations: Strategic alliances with other pharmaceutical companies or research institutions can enhance Cellectar's credibility and resources, potentially leading to price appreciation. Conversely, the dissolution of such partnerships can negatively affect the stock.

News and Announcements: Significant news events, such as product updates, leadership changes, or major acquisitions, can create volatility in the stock price, depending on how investors interpret the news.

Analyst Ratings: Ratings and price targets issued by financial analysts influence investor perceptions of CLRB.US. Positive ratings tend to attract buyers, while negative ratings can lead to selling pressure.

People Also Watch

Research

Market Performance Overview: S&P 500 Rose 1.18%, Earnings Season Q1 2026, Crypto Positive Sentiment

Market Performance Overview: S&P 500 Rose 1.18%, Earnings Season Q1 2026, Crypto Positive Sentiment

Ghko B|--
Apple (AAPL) stock overview: Apple Q2 2026 earnings are coming, what to expect on April 30?

Apple (AAPL) stock overview: Apple Q2 2026 earnings are coming, what to expect on April 30?

Frances Wang|--
Crypto market outlook: South Africa Crypto Market Forecast to Reach $25 Billion by 2033

Crypto market outlook: South Africa Crypto Market Forecast to Reach $25 Billion by 2033

Ghko B|--
BTC, ETH, XRP: What’s going on with the top 3 cryptos?

BTC, ETH, XRP: What’s going on with the top 3 cryptos?

Ghko B|--
Best crypto brokers in South Africa (2026): Binance, Luno, Coinbase and more

Best crypto brokers in South Africa (2026): Binance, Luno, Coinbase and more

Ghko B|--

Latest news

Hormuz Strait Control: Iran's Post-War Maritime Ambitions and Global Repercussions

Emma Rose|--

Global Market Analysis and Geopolitical Shifts: An In-Depth Look

Emma Rose|--

Tesla Stock Plummets Over 5% on Disappointing Q1 Delivery and Production Figures

Sophia Claire|--

Latest Education Articles

Black Swan Events Explained: What They Mean for the Stock Market and Your Money

Black Swan Events Explained: What They Mean for the Stock Market and Your Money

Julian Parker|--
How to Use AI in Trading: Tools, Strategies, Benefits & Risks

How to Use AI in Trading: Tools, Strategies, Benefits & Risks

Julian Parker|--
How to Trade Bitcoin (BTC/USD) CFDs in South Africa: A Complete Beginner’s Guide for 2026

How to Trade Bitcoin (BTC/USD) CFDs in South Africa: A Complete Beginner’s Guide for 2026

Ghko B|--
Recommended Topics